Author
Harvard UniversityORCID 0000-0001-9896-8084Unclaimed ORCID profile · follow to get notified of new preprints
Mutual co-authors in cluster
4 papers
Recent·Most cited
Christopher E. Lietz, Erik T. Newman, Andrew D. Kelly…·Dimitrios Spentzos
The paper identifies a dynamic microRNA profile associated with chemotherapy resistance in osteosarcoma and predicts novel therapeutic targets that could reverse resistance.
Christopher E. Lietz, Erik T. Newman, Andrew D. Kelly…·Dimitrios Spentzos
This study identifies DNA methylation subtypes in osteosarcoma that predict clinical outcomes and response to chemotherapy.
Christopher B. Lietz, Cassandra C. Garbutt, William Thomas Barry…·Dimitrios Spentzos
The paper identifies microRNA-mRNA networks associated with prognosis in osteosarcoma and validates their predictive value across independent datasets.
Katherine E. Hill, Ahmed Rattani, Christopher E. Lietz…·Dimitrios Spentzos
The paper develops a multi-gene signature predicting PARP inhibitor response across cancer types using machine learning and validates it in vitro and in clinical datasets.